drugset
drugset / Trial / NCT07866443

Combination of Pregabalin and Trigger Point Injection With Ropivacaine in the Treatment of Myofascial Pain Syndrome of the Neck and Upper Back.

NCT07866443 ↗

Phase 4 Completed 74 enrolled National and Kapodistrian University of Athens
RandomizedParallel-groupOpen-labelTreatment

Summary

This study compared trigger point injections with ropivacaine alone versus trigger point injections combined with oral pregabalin in adults with chronic myofascial pain of the neck and upper back. Participants were randomly assigned to one of the two treatment groups. Pain intensity, number of trigger points, neuropathic pain symptoms, and health-related quality of life were assessed at baseline and at 1 and 3 months after treatment.

Timeline

Start
2025-03-01
Primary completion
2025-12-20
Completion
2025-12-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 50 mg Oral
Subject Ropivacaine Other / unclassified 0.2 % Other
Subject Ropivacaine Other / unclassified 2 ml Other

Indications

myofascial pain syndrome